The primary treatment for
ARDS involves the use of mechanical ventilation devices.
Bellingan discussed potential mechanisms by which MultiStem may be providing benefit to
ARDS patients, such as through restored endothelial integrity of the lung, reduced lung edema, increased alveolar fluid clearance, reduced immune cell infiltrate (including neutrophils, macrophages and eosinophils), and the ability to shift immune cells from a proinflammatory to anti-inflammatory phenotype.
"
Ards will be in for a difficult game, that's for sure.
Classically,
ARDS is recognized to be an inflammatory lung injury.
Washington D.C [USA] Aug 29( ANI ): Researchers have devised a model to predict burn patients who are most likely to develop life-threatening acute respiratory distress syndrome (
ARDS).
Therefore, they are regarded as a sensible option in the treatment of
ARDS (6).
Groeneveld, M.D., from Leiden University Medical Center in the Netherlands, and colleagues compared the incidence of
ARDS after surgery during influenza seasons with the incidence of
ARDS after surgery during seasons with few influenza cases in a retrospective cohort study involving patients who underwent cardiac surgery between January 2009 and January 2012.
Unfortunately, although a variety of
ARDS studies have been conducted, there is no favorable prediction model for
ARDS.
The question here is how to manage the supportive treatment period in
ARDS. For this aim, we have the possibility of increasing the Fi[O.sub.2] level by several methods (such as high flow nasal [O.sub.2], therapy 'HFNOT' and non-rebreathing masks) or the application of invasive/non-invasive MV for a period to allow time for curative treatments.
Acute respiratory distress syndrome (
ARDS) is a life threatening respiratory failure due to direct or indirect lung injury caused by many aetiological factors.
"Over the last 20-30 years researchers have come up with novel therapies but have not been able to move the needle substantially in terms of reducing mortality of
ARDS patients," explains Professor Anand of Stanford University, USA.